Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BCC PharmaBase AB
AB
Active
Org 5592247174
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 6 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BCC PharmaBase AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: not reported
2023
2024: 0M
0M
2024
2025: not reported
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
—
0
—
0
0
Staff expenses
—
—
—
—
—
EBITDA
−13
−25
−7
−5
−10
Depreciation & amort.
—
—
—
—
−0
EBIT
−13
−25
−7
−5
−10
Net financials
787
509
1
372
—
Profit before tax
774
485
−5
367
−10
Tax
—
—
—
—
−0
Net profit
774
485
−5
367
−10
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
852
545
48
403
36
Equity
847
533
48
403
36
Long-term debt
—
—
—
—
0
Short-term debt
5
12
—
0
0
Total debt
5
12
—
—
—
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
99,4 %
This company
38,2 %
Market median
This company
Market median
160% above market
2021
2025
Return on equity
91,4 %
This company
18,4 %
Market median
This company
Market median
397% above market
2021
2025
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0,01×
This company
0,62×
Market median
This company
Market median
98% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on BCC PharmaBase AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
